title: Randomised controlled trial of zinc supplementation in malnourished Bangladeshi children with acute diarrhoea.
abstract: OBJECTIVE
  To evaluate the impact of zinc supplementation on the clinical course, stool weight, duration of diarrhoea, changes in serum zinc, and body weight gain of children with acute diarrhoea.
  
  
  METHODS
  Randomised double blind controlled trial. Children were assigned to receive zinc (20 mg elemental zinc per day) containing multivitamins or control group (zinc-free multivitamins) daily in three divided doses for two weeks.
  
  
  METHODS
  A diarrhoeal disease hospital in Dhaka, Bangladesh.
  
  
  METHODS
  111 children, 3 to 24 months old, below 76% median weight for age of the National Center for Health Statistics standard with acute diarrhoea. Children with severe infection and/or oedema were excluded.
  
  
  METHODS
  Total diarrhoeal stool output, duration of diarrhoea, rate of weight gain, and changes in serum zinc levels after supplementation.
  
  
  RESULTS
  Stool output was 28% less and duration 14% shorter in the zinc supplemented group than placebo (p = 0.06). There were reductions in median total diarrhoeal stool output among zinc supplemented subjects who were shorter (less than 95% height for age), 239 v 326 g/kg (p < 0.04), and who had a lower initial serum zinc (< 14 mmol/l), 279 v 329 g/kg (p < 0.05); a shortening of mean time to recovery occurred (4.7 v 6.2 days, p < 0.04) in those with lower serum zinc. There was an increase in mean serum zinc in the zinc supplemented group (+2.4 v -0.3 mumol/l, p < 0.001) during two weeks of supplementation, and better mean weight gain (120 v 30 g, p < 0.03) at the time of discharge from hospital.
  
  
  CONCLUSIONS
  Zinc supplementation is a simple, acceptable, and affordable strategy which should be considered in the management of acute diarrhoea and in prevention of growth faltering in children specially those who are malnourished.
authors.affiliation: Clinical Sciences Division, International Centre for Diarrhoeal Diseases Research, Dhaka, Bangladesh.
authors.forename: S K
authors.initials: SK
authors.lastname: Roy
authors.forename: A M
authors.initials: AM
authors.lastname: Tomkins
authors.forename: S M
authors.initials: SM
authors.lastname: Akramuzzaman
authors.forename: R H
authors.initials: RH
authors.lastname: Behrens
authors.forename: R
authors.initials: R
authors.lastname: Haider
authors.forename: D
authors.initials: D
authors.lastname: Mahalanabis
authors.forename: G
authors.initials: G
authors.lastname: Fuchs
mesh_terms: D000208:Acute Disease; D002675:Child, Preschool; D003968:Diarrhea, Infantile / Q000150:complications / Q000628:therapy*; D004311:Double-Blind Method; D005243:Feces; D006801:Humans; D007223:Infant; D009748:Nutrition Disorders / Q000150:complications / Q000628:therapy*; D013997:Time Factors; D016896:Treatment Outcome; D015430:Weight Gain / Q000187:drug effects; D015032:Zinc / Q000097:blood / Q000172:deficiency / Q000627:therapeutic use*
chemical_list: D015032:Zinc